Literature DB >> 24011697

Struggling with myelofibrosis-associated anemia.

Paola Guglielmelli1, Alessandro M Vannucchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24011697     DOI： 10.1016/j.leukres.2013.08.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.

Authors:  Brady L Stein; Jason Gotlib; Murat Arcasoy; Marie Huong Nguyen; Neil Shah; Alison Moliterno; Catriona Jamieson; Daniel A Pollyea; Bart Scott; Martha Wadleigh; Ross Levine; Rami Komrokji; Rebecca Klisovic; Krishna Gundabolu; Patricia Kropf; Meir Wetzler; Stephen T Oh; Raul Ribeiro; Rita Paschal; Sanjay Mohan; Nikolai Podoltsev; Josef Prchal; Moshe Talpaz; David Snyder; Srdan Verstovsek; Ruben A Mesa
Journal:  J Natl Compr Canc Netw       Date:  2015-04       Impact factor: 11.908

2.  Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations.

Authors:  D Barraco; Y C Elala; T L Lasho; K H Begna; N Gangat; C Finke; C A Hanson; R P Ketterling; A Pardanani; A Tefferi
Journal:  Blood Cancer J       Date:  2016-04-08       Impact factor: 11.037

3.  The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis.

Authors:  Mary Frances McMullin; Claire N Harrison; Dietger Niederwieser; Hilde Demuynck; Nadja Jäkel; Prashanth Gopalakrishna; Mari McQuitty; Viktoriya Stalbovskaya; Christian Recher; Koen Theunissen; Heinz Gisslinger; Jean-Jacques Kiladjian; Haifa-Kathrin Al-Ali
Journal:  Exp Hematol Oncol       Date:  2015-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.